ULBIMEDIUM SIGNALOPERATIONAL10-K

ULBI streamlined its corporate structure by divesting several subsidiaries while achieving solid revenue growth and strengthening its cash position.

The removal of multiple subsidiaries from the corporate structure indicates meaningful portfolio simplification, potentially through divestitures that could enhance operational focus. The company appears to be concentrating on core operations while maintaining growth momentum. However, investors should monitor whether this restructuring impacts long-term growth capabilities.

Comparing 2026-03-23 vs 2025-04-01View on EDGAR →
FINANCIAL ANALYSIS

ULBI delivered solid operational performance with revenue growing 16.2% to $191.2M while strengthening its balance sheet through a 36.3% increase in cash to $9.3M and nearly halving interest expense. However, the company faced margin pressure as both R&D and SG&A expenses grew faster than revenue, contributing to a 33.9% decline in operating cash flow to $11.0M. The financial profile suggests a company investing for growth while managing working capital challenges, as evidenced by rising accounts receivable and current liabilities.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
-45.9%
$440K$238K

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Cash & Equivalents
Balance Sheet
+36.3%
$6.9M$9.3M

Cash position surged 36.3% — strong cash generation or capital raise providing significant financial cushion.

Operating Cash Flow
Cash Flow
-33.9%
$16.6M$11.0M

Operating cash flow fell 33.9% — earnings quality concerns; investigate working capital changes and non-cash items.

Current Liabilities
Balance Sheet
+27.5%
$29.3M$37.3M

Current liabilities rose 27.5% — increased short-term obligations, watch current ratio.

R&D Expense
P&L
+25.8%
$8.3M$10.4M

R&D investment increased 25.8% — signals commitment to future product development, though near-term margin impact.

SG&A Expense
P&L
+21.9%
$24.1M$29.3M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Revenue
P&L
+16.2%
$164.5M$191.2M

Revenue growing 16.2% — solid top-line momentum, watch margins for quality of growth.

Accounts Receivable
Balance Sheet
+15.6%
$29.4M$33.9M

Receivables grew 15.6% — monitor days sales outstanding for collection efficiency.

LANGUAGE CHANGES
NEW — 2026-03-23
PRIOR — 2025-04-01
ADDED
As of March 20, 2026, the registrant had 16,656,503 shares of common stock outstanding.
and foreign governments; our exposure to foreign currency fluctuations; our ability to utilize our net operating loss carryforwards; the risk that we are unable to protect our proprietary and intellectual property; our ability to comply with government regulations regarding the use of conflict minerals ; possible impairments of our goodwill and other intangible assets; known and unknown environmental matters; possible audits of our contracts by the U.S.
and foreign governments and their respective defense agencies; exposure to possible violations of the U.S.
Bribery Act or other anti-corruption laws; and other risks and uncertainties, certain of which are beyond our control.
As used in this Form 10-K Annual Report, unless otherwise indicated, the terms the Company , we , our and us refer to Ultralife Corporation ( Ultralife ) and its wholly owned subsidiaries ABLE New Energy Co., Limited and its wholly owned subsidiary ABLE New Energy Co., Ltd.
+7 more — sign up free →
REMOVED
As of March 28, 2025, the registrant had 16,632,965 shares of common stock outstanding.
and foreign governments; exposure to possible violations of the U.S.
Bribery Act or other anti-corruption laws; known and unknown environmental matters; possible audits of our contracts by the U.S.
and foreign governments and their respective defense agencies; our ability to comply with government regulations regarding the use of conflict minerals ; and other risks and uncertainties, certain of which are beyond our control.
As used in this Form 10-K Annual Report, unless otherwise indicated, the terms the Company , we , our and us refer to Ultralife Corporation ( Ultralife ) and its wholly owned subsidiaries ABLE New Energy Co., Limited and its wholly owned subsidiary ABLE New Energy Co., Ltd (collectively ABLE ); Ultralife UK LTD and its wholly owned subsidiary Accutronics Ltd (collectively Accutronics ); Ultralife Batteries (UK) Ltd.; Southwest Electronic Energy Corporation and its wholly owned subsidiary, CLB, Inc.
+7 more — sign up free →
MORE OPERATIONAL SIGNALS
NVDAHIGHNVIDIA has repositioned itself from a "full-stack computing infrastructure compa...
2026-02-25
NVDAHIGHNVIDIA has repositioned itself from a "full-stack computing infrastructure compa...
2026-02-25
NOWHIGHServiceNow has fundamentally repositioned itself as an AI-first platform company...
2026-01-29
TSLAHIGHTesla has fundamentally repositioned itself from an electric vehicle company to ...
2026-01-29
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →